(Q44123589)

30 November 2017

title

Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant (English)

1 reference

non-small-cell lung carcinoma

30 November 2017

0 references

1 reference

Rob MacRae

1

1 reference

30 November 2017

Yu Shyr

series ordinal

2

1 reference

30 November 2017

David Johnson

series ordinal

3

1 reference

30 November 2017

Hak Choy

series ordinal

4

1 reference

30 November 2017

publication date

1 July 2002

1 reference

Radiotherapy and Oncology

30 November 2017

published in

1 reference

30 November 2017

volume

64

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

37-40

1 reference

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

The effect of arterial oxygen content on the results of radiation therapy for epidermoid bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

A practical prognostic index for inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900151-2

7 January 2021

10.1016/S0167-8140(02)00151-2

Identifiers

DOI

1 reference

30 November 2017

1 reference